These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8607674)

  • 1. Specific complement inhibition with heparin-coated extracorporeal circuits.
    te Velthuis H; Jansen PG; Hack CE; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1996 Apr; 61(4):1153-7. PubMed ID: 8607674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin coating with aprotinin reduces blood activation during coronary artery operations.
    Baufreton C; Jansen PG; Le Besnerais P; te Velthuis H; Thijs CM; Wildevuur CR; Loisance DY
    Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo.
    Videm V; Mollnes TE; Bergh K; Fosse E; Mohr B; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):803-9. PubMed ID: 10096977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E; Fosse E; Mollnes TE; Am Holen E; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    Eur J Cardiothorac Surg; 1996; 10(1):54-60. PubMed ID: 8776186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
    Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes TE; Fagerhol MK; Venge P
    Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.
    Gu YJ; van Oeveren W; Akkerman C; Boonstra PW; Huyzen RJ; Wildevuur CR
    Ann Thorac Surg; 1993 Apr; 55(4):917-22. PubMed ID: 8466349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.
    Shastri KA; Logue GL; Stern MP; Rehman S; Raza S
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):482-8. PubMed ID: 9305203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
    Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.
    Kirschfink M; Kovacs B; Mottaghy K
    Circ Shock; 1993 Jul; 40(3):221-6. PubMed ID: 8348684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
    Moen O; Fosse E; Brockmeier V; Andersson C; Mollnes TE; Høgåsen K; Venge P
    Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces.
    Kopp R; Mottaghy K; Kirschfink M
    ASAIO J; 2002; 48(6):598-605. PubMed ID: 12455769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.